Related Experiment Video
Updated: Mar 13, 2026

Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Hypercoagulable States: What the Oral Surgeon Needs to Know
1Frank H. Netter School of Medicine, Quinnipiac University, 275 Mount Carmel Avenue, MNH 307L, Hamden, CT 06518-1908, USA.
Thrombophilia, or hypercoagulable conditions, are inherited or acquired disorders that increase blood clot risk. Inherited forms include gene mutations and protein deficiencies, while acquired forms are linked to cancer and other conditions.
Area of Science:
- Hematology
- Genetics
- Internal Medicine
Background:
- Thrombophilia encompasses inherited and acquired conditions leading to hypercoagulability.
- Inherited thrombophilias include deficiencies in antithrombin, protein C, or protein S, and Factor V Leiden or prothrombin gene mutations.
- Acquired thrombophilias are associated with conditions like cancer, antiphospholipid antibodies, and endothelial dysfunction.
Purpose of the Study:
- To provide an overview of inherited and acquired thrombophilic conditions.
- To highlight the genetic basis and clinical implications of thrombophilia.
Main Methods:
- Literature review of inherited and acquired thrombophilias.
- Analysis of genetic factors and clinical associations.
Main Results:
- Inherited thrombophilias are autosomal dominant and primarily predispose to venous thrombosis.
- Acquired thrombophilic states result from various conditions affecting coagulation, platelet function, or the endothelium.
Conclusions:
- Understanding the distinct mechanisms of inherited and acquired thrombophilia is crucial for risk assessment and management.
- Further research into acquired thrombophilias can elucidate complex interactions affecting hemostasis.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Tonsillitis II: Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management